Hypoglossal Nerve Palsy

Comprehensive Clinical Guide: Hypoglossal Nerve Palsy (CN XII)

Hypoglossal nerve palsy represents a significant clinical manifestation of localized pathology involving the twelfth cranial nerve. As the primary motor nerve responsible for the intrinsic and extrinsic musculature of the tongue (with the exception of the palatoglossus), the hypoglossal nerve is critical for speech, mastication, and deglutition. Damage to this nerve—whether central, nuclear, or peripheral—results in profound functional deficits that necessitate a structured diagnostic and therapeutic approach.

1. Introduction and Overview

The hypoglossal nerve (CN XII) is a purely motor nerve that emerges from the hypoglossal nucleus in the medulla oblongata. It exits the cranium through the hypoglossal canal and descends into the neck, eventually reaching the tongue. Clinical presentation of palsy often involves unilateral or bilateral tongue weakness, atrophy, and fasciculations.

Because of its complex anatomical trajectory—traversing the skull base, the carotid sheath, and the submandibular space—it is vulnerable to a wide array of pathologies, including neoplastic infiltration, trauma, vascular accidents, and inflammatory processes. A diagnosis of hypoglossal nerve palsy is rarely an isolated clinical event; it is frequently a "sentinel sign" of underlying systemic or localized disease.

2. Technical Specifications and Pathophysiology

The Anatomical Pathway

The hypoglossal nerve's course can be divided into four distinct segments:
1. Intramedullary: Originates from the hypoglossal nucleus in the floor of the fourth ventricle.
2. Cisternal: Exits the medulla via the pre-olivary sulcus and traverses the subarachnoid space.
3. Canalicular: Passes through the hypoglossal canal within the occipital bone.
4. Extracranial: Descends between the internal carotid artery and the internal jugular vein, loops around the occipital artery, and enters the tongue base.

Mechanisms of Injury

• Nuclear/Infranuclear Lesions: Often associated with brainstem strokes, syringobulbia, or motor neuron disease (ALS).
• Skull Base Pathologies: Glomus tumors (paragangliomas), clivus chordomas, or metastatic skull base lesions.
• Neck/Soft Tissue Pathology: Carotid artery dissection, neck surgery complications (carotid endarterectomy), or penetrating trauma.
• Iatrogenic Causes: Post-intubation injury or complications from radical neck dissections.

3. Clinical Indications and Presentation

The clinical diagnosis of hypoglossal nerve palsy is largely based on physical examination of the oral cavity and neck.

Key Clinical Signs

• Atrophy: Unilateral wasting of the tongue musculature.
• Fasciculations: Spontaneous, fine contractions of the tongue, often indicating lower motor neuron (LMN) involvement.
• Deviation: Upon protrusion, the tongue deviates toward the side of the lesion (the "weak" side).
• Dysarthria: Difficulty articulating lingual consonants (e.g., /t/, /d/, /n/, /l/).
• Dysphagia: Difficulty in bolus formation and movement of food to the oropharynx.

Clinical Staging/Grading (Modified Functional Scale)

While there is no universally standardized staging system for CN XII palsy, clinicians often utilize a functional assessment:

4. Differential Diagnosis

Distinguishing between upper motor neuron (UMN) and lower motor neuron (LMN) lesions is the primary clinical task.

• UMN Lesion: Contralateral tongue weakness. The tongue deviates away from the side of the lesion. There is usually no atrophy or fasciculations.
• LMN Lesion: Ipsilateral tongue weakness. The tongue deviates toward the side of the lesion. Atrophy and fasciculations are hallmark features.
• Myasthenia Gravis: Fluctuating weakness that typically worsens with fatigue.
• Lingual Nerve Injury: Sensory loss without motor atrophy (distinguishes it from CN XII palsy).

5. Diagnostic Protocol

A systematic approach is required to rule out life-threatening etiologies.

1. Neurological Examination: Assessment of all cranial nerves to rule out "Collet-Sicard syndrome" (involvement of CN IX, X, XI, and XII).
2. Imaging (Gold Standard):
3. MRI of the Brain and Skull Base: With contrast, specifically focusing on the hypoglossal canal and the carotid sheath.
4. CT Angiography/MRA: To rule out carotid artery dissection or aneurysms.
5. Electromyography (EMG): Used to confirm denervation of the lingual muscles and differentiate from primary myopathic processes.
6. Blood Work: ESR/CRP for inflammatory conditions, ACE levels for sarcoidosis, and paraneoplastic panels if malignancy is suspected.

6. Risks, Side Effects, and Complications

The primary risks associated with hypoglossal nerve palsy are functional and nutritional:
* Aspiration Pneumonia: Due to the inability to control the food bolus, the risk of silent aspiration is high, particularly in elderly patients.
* Malnutrition/Dehydration: Failure to thrive due to dysphagia.
* Psychosocial Impact: Significant impairment in communication and social interaction, leading to depression and social isolation.

7. Prognosis and Management

Prognosis is entirely dependent on the underlying etiology.
* Traumatic: Often shows partial recovery over 6–12 months.
* Neoplastic: Prognosis is dictated by the primary tumor stage and response to radiation/surgery.
* Idiopathic: Often shows spontaneous recovery, though steroids are sometimes prescribed empirically.

Management Strategies:
* Speech-Language Pathology (SLP): Essential for compensatory swallowing strategies and speech therapy.
* Dietary Modification: Thickened liquids and pureed diets to mitigate aspiration risk.
* Surgical Exploration: Reserved for cases of space-occupying lesions at the skull base.

8. Frequently Asked Questions (FAQ)

1. Does a tongue deviation always mean a tumor?

No. While tumors are a major concern, strokes, trauma, and even viral mononeuritis can cause temporary or permanent palsy. Imaging is required to differentiate.

2. Can hypoglossal nerve palsy be reversed?

If the nerve is compressed by a treatable lesion (e.g., a benign tumor), surgical decompression can lead to recovery. If the nerve is severed, recovery is unlikely without nerve grafting.

3. What is the difference between a "weak" tongue and "atrophic" tongue?

Weakness is a functional deficit. Atrophy is a structural change where the muscle mass decreases, causing the tongue to appear shriveled and "wrinkled" on the affected side.

4. Is dysphagia common with this condition?

Yes. Because the tongue is vital for manipulating food into a bolus, unilateral palsy often causes food to pocket in the cheek, while bilateral palsy causes severe difficulty with swallowing.

5. What is the "Collet-Sicard Syndrome"?

It is a rare condition where the last four cranial nerves (IX, X, XI, XII) are affected, usually due to a tumor at the base of the skull.

6. Do I need an MRI or a CT scan?

An MRI is superior for evaluating the soft tissues, the brainstem, and the course of the nerve through the skull base. CT is better for evaluating bony structures (e.g., fracture of the occipital condyle).

7. How long does it take for the tongue to atrophy?

Visible atrophy generally occurs within 2 to 4 weeks following complete denervation of the tongue muscles.

8. Are fasciculations always a sign of ALS?

No, but they are a hallmark of lower motor neuron disease. While ALS is a differential, many other processes (syringomyelia, tumors) can cause fasciculations.

9. Can I still talk with a hypoglossal nerve palsy?

Yes, but speech will be slurred, particularly with lingual sounds. The brain often compensates by using the lips and cheeks, but clarity is significantly reduced.

10. What is the first step if I notice my tongue is moving to one side?

Seek a neurology consultation immediately. A clinical exam will determine if the lesion is central or peripheral, which dictates the urgency of imaging.

9. Clinical Conclusion

Hypoglossal nerve palsy is a focal neurological deficit that demands a high index of suspicion. While the functional impact is localized to the oral cavity, the diagnostic implications are systemic. Clinicians must prioritize the differentiation between UMN and LMN lesions, utilize high-resolution imaging to evaluate the entire course of the nerve, and engage multidisciplinary support—including Speech-Language Pathology and Nutrition—to manage the patient's quality of life. Early identification of the underlying cause remains the single most important factor in determining the long-term prognosis for the patient.